This page contains a Flash digital edition of a book.
NEWS


STROLL DOWN MEMORY LANE FOR


WORSLEY’S ELDERLY Care home residents in Worsley, Greater Manchester, have been researching their past as part of a Salford Museum reminiscence activity.


Rationing, wartime and how life has changed were just some of the topics being discussed by residents at Alderwood Care Home.


The Memory Matters service provides a mixture of photos, diaries, news clippings, displays and other assorted items to help elicit residents’ memories.


Roy and Rose Healey, who married in March 1956 and recently celebrated their 61st


wedding anniversary,


enjoyed taking a stroll down memory lane together.


SHOULD MORE BE DONE TO PREVENT HARM TO CHEMOTHERAPY


NURSES? The question of whether enough is being done to protect chemotherapy nurses from exposure to hazardous drugs has been raised following new research from MindMetre.


Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.


Having considered the body of evidence that has emerged in Europe, MindMetre is raising the question of whether official guidelines should be interpreted more rigorously or even whether further specific legislation/regulation should be introduced.


twitter.com/TomorrowsCare


The MindMetre research note draws on a variety of different pieces of evidence that, together, suggest that the question of potential damage to staff administering hazardous cancer drugs should at least be further scrutinised.


A number of robust studies from around the USA and Europe have confirmed harm is being sustained from such exposure and, in the UK specifically, some chemotherapy nurses have reported significant symptoms, such as hair loss and an unusually high rate of miscarriages.


As well as investigating claims about the effects of such exposure, the MindMetre report considers whether measurement and monitoring of exposure levels is sufficiently rigorous. A recent investigation in a Spanish hospital found that cytotoxic drug contamination levels on the ward were extremely high. The report notes that many national regulations in Europe make specific reference to U.S. National Institute for Occupational Safety and Health (NIOSH) guidelines mandating the use of ‘closed systems’ to prevent any escape of hazardous drugs, from the point of preparation to administration and disposal. NIOSH


Roy said: “I was looking at the ration book and we were discussing what it was like to grow up on rations. We used to collect green shield stamps and we’d spend hours looking through the catalogues deciding what to buy.”


Rose added: “We don’t know how lucky we are today with all the choices we have.”


Alderwood Care Home uses the Salford Museum service regularly, as the activity has proven beneficial for residents.


Cher Jarvis, Home Manager, said: “The service encourages independent viewing – so the residents do their own research.


“It’s a great resource to prompt conversation and interaction through recognition of objects that elicit memories.”


www.hillcare.net


defines closed systems as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapour concentrations outside the system.” Initial evidence suggests that this definition is not consistent with current transfer and administration protocols, and that contamination is not being regularly monitored at the ward level. In the paper, MindMetre notes that although the risk of contamination has been widely recognised across Europe, there is not yet any Europe- wide specific legislation, guidelines or minimum standards to precisely define administration processes.


Paul Lindsell, Managing Director of MindMetre Research, noted: “The evidence strongly suggests that nurses who are regularly administering chemotherapy drugs are at risk of developing health problems as a result of their prolonged exposure to cytotoxic chemicals. It appears that regulation and, more importantly, prevention of the occupational risks that these healthcare workers face is not rigorous enough which raises serious questions of morality.”


To see the full report, click here. - 7 -


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52